Is NAD+ a peptide?

A common search is "is NAD+ a peptide?" — and the short answer is no. Nicotinamide adenine dinucleotide (NAD+) is a pyridine nucleotide coenzyme, not a chain of amino acids. It is grouped with peptides commercially because researchers in the same fields work with both, but chemically it is a different class of molecule entirely.

Research use only. NAD+ is supplied strictly for in-vitro laboratory research. This page does not describe dosing, administration, or use in humans or animals, and makes no therapeutic claims.

What NAD+ is

NAD+ is an endogenous coenzyme and signalling molecule central to cellular metabolism. In its oxidised form it participates in the electron-transfer reactions that underpin oxidative phosphorylation, glycolysis and mitochondrial energy production. It exists in a balance with its reduced form (NADH), and the NAD+/NADH ratio is a key variable in metabolic research.

Why it gets called a "NAD peptide"

The phrase turns up constantly, and it is a category error rather than a synonym. The confusion is understandable: NAD⁺ is sold by the same suppliers, studied in the same laboratories and discussed in the same forums as research peptides, so the label attaches by association.

Structurally the two are unrelated:

A peptide is a chain of amino acids linked by peptide bonds. NAD⁺ is a dinucleotide — two nucleotides, nicotinamide mononucleotide and adenosine monophosphate, joined through their phosphate groups. There is no amino acid anywhere in the structure and no peptide bond. Calling it a peptide is roughly like calling a sugar a protein.

This matters practically as well as pedantically: because NAD⁺ is not a peptide, it does not behave like one in solution. Its stability profile is different, and it is notably pH-sensitive — see our guide on bacteriostatic water and solution stability, where NAD⁺ is the worked example.

The four forms: NAD+, NADH, NADP+ and NADPH

Sources use these interchangeably and they are not interchangeable. The distinction is the first thing to get right, because a protocol that specifies one and receives another is measuring something else.

NAD+ and NADP+ differ by a single phosphate group on the adenosine ribose, and that one group separates two largely distinct metabolic economies: the NAD+/NADH couple runs energy catabolism, while the NADP+/NADPH couple runs biosynthesis and antioxidant defence. Cells maintain them at very different ratios for exactly that reason.

Where cellular NAD+ comes from

Three routes are described in the literature, and knowing which one a given experiment is probing matters more than it might appear.

• The salvage pathway — the dominant route in most mammalian cells. Nicotinamide released by NAD+-consuming enzymes is recycled via nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting step, and this is where most pharmacological interest concentrates.
• The Preiss-Handler pathway — from dietary nicotinic acid.
• De novo synthesis — from tryptophan via the kynurenine pathway. Real but a minor contributor in most tissues.

Because the salvage pathway dominates, NAD+ levels in a cultured system are governed largely by the balance between NAMPT activity and the rate at which NAD+-consuming enzymes are working. That is why NAD+ concentration is a dependent variable in most experiments rather than a fixed input.

NAD+, NMN and NR — a common confusion

These three appear together constantly and are distinct molecules.

• NAD+ is the coenzyme itself.
• NMN (nicotinamide mononucleotide) is the immediate precursor, one enzymatic step away.
• NR (nicotinamide riboside) sits one step further back, converted to NMN and then to NAD+.

The practical distinction for laboratory work is molecular size and charge: NAD+ is a comparatively large, highly charged dinucleotide, which is precisely why the precursors attract research attention as more tractable routes to raising intracellular NAD+ in a model system. A study using NR is not a study of NAD+, and results are not interchangeable between them.

Why NAD+ decline is studied

A recurring theme in the literature is that measured NAD+ levels decline with age across a range of tissues and model organisms. The mechanisms proposed include increased consumption by PARPs responding to accumulated DNA damage, altered NAMPT expression, and shifts in the activity of other NAD+-consuming enzymes.

This is the observation behind most current interest in the molecule, and it is worth stating what it is and is not. It is a reproducible observation in laboratory systems. It is not, on its own, evidence that any intervention reverses an outcome in a person — the step from a measured biochemical decline to a clinical benefit is exactly the step that remains under investigation, and we make no claim about it.

What researchers study

In biochemical and cellular systems, NAD+ is studied for its role in redox balance and as a substrate for NAD+-dependent enzymes, including:

• Sirtuins — implicated in chromatin regulation
• Poly(ADP-ribose) polymerases (PARPs) — implicated in DNA repair
• Cyclic ADP-ribose-generating enzymes — implicated in calcium signalling

Experimental outcomes depend heavily on intracellular NAD+/NADH ratios, compartmentalisation and the metabolic state of the model, so NAD+ is widely used as a reference compound in enzymology and metabolic research.

NAD+ and MOTS-c

The two are frequently studied together, and the link is mechanistic. AMPK — the cell's principal energy sensor and the pathway most examined in MOTS-c research — and the NAD⁺/sirtuin axis are interconnected energy-sensing systems. A laboratory investigating cellular energy regulation usually has reason to look at both. See what is MOTS-c peptide?.

Handling: why NAD+ is less forgiving than a peptide

Because NAD+ is not a peptide, it does not behave like one, and the differences are practical rather than academic.

pH is the dominant variable. NAD+ degrades under both acidic and alkaline conditions, and the oxidised and reduced forms have opposite sensitivities — NAD+ is the more stable of the pair in acid, NADH in base. A buffer chosen for a peptide protocol is not automatically appropriate here.

Solutions do not keep. Aqueous NAD+ degrades measurably over time even refrigerated, so it is prepared close to use rather than stored in solution for long periods. Freeze-thaw cycling makes this worse.

Degradation is not always visible. A peptide solution that has gone off often gives some visual cue. NAD+ can lose a meaningful fraction of its activity while looking unchanged, which is why preparation date matters more than appearance.

Our guide on bacteriostatic water and solution stability uses NAD+ as the worked example, because it is the compound in our catalogue where solution handling makes the largest difference to what you actually have.

What this page deliberately does not cover

Much of the search interest around NAD+ concerns intravenous NAD+ therapy — clinic-administered infusions marketed for energy, recovery or ageing. We do not supply that, we are not a clinic, and we are not going to write about it as though we were.

The NAD+ we supply is a laboratory reference compound for in-vitro research. It is not an infusion product, not a supplement, and not for human or veterinary use. If you are researching IV NAD+ therapy as a consumer, a regulated clinical provider is the correct source of information and this page is not it.

We also publish no dosing, reconstitution-for-use or administration guidance, for the same reason: quantity guidance aimed at a person would be inconsistent with what is actually being supplied.

How it is supplied

The NAD+ Kit is supplied with a batch-specific Certificate of Analysis recording identity and purity for the lot you receive, dispatched from our UK facility under cold-chain handling. As with everything we supply it is for in-vitro laboratory research only.

Given the stability profile above, the batch date on the certificate is worth more attention here than it would be for a lyophilised peptide. Recent certificates are viewable in the COA library before ordering.

For working out concentrations from a vial, use the peptide calculator.

Related reading

• New to the topic? Start with what are research peptides?